NKI-AVL, Department of Thoracic-Oncology
About NKI-AVL, Department of Thoracic-Oncology
The Netherlands Cancer Institute in Amsterdam was founded in 1913 by, among others, the surgeon Jacob Rotgans. The NKI, together with the Antoni van Leeuwenhoekziekenhuis, is formed into the NKI-AVL, which combines a scientific research institute with a specialized clinic focused on combating the disease cancer.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at NKI-AVL, Department of Thoracic-Oncology
During the past decade, NKI-AVL, Department of Thoracic-Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS) - Industrial Workers
2009-01-01
2010-02-01
Completed
522
Effect of Personal Versus Video Instruction in Elastic Resistance Exercise on Technical Execution (IRMA05)
2012-03-01
2012-06-01
Completed
38
Implementation of Physical Exercise at the Workplace (IRMA06) - Slaughterhouse Workers
2012-08-01
2013-02-01
Completed
66
Implementation of Physical Exercise at the Workplace (IRMA08) - Healthcare Workers
2013-09-01
2014-01-01
Completed
200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NKI-AVL, Department of Thoracic-Oncology
According to Clinical.Site data, the most researched conditions in "NKI-AVL, Department of Thoracic-Oncology" are
"ALK-positive Non-small Cell Lung Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "NKI-AVL, Department of Thoracic-Oncology" in a lesser frequency.
Clinical Trials Intervention Types at NKI-AVL, Department of Thoracic-Oncology
Most popular intervention types in "NKI-AVL, Department of Thoracic-Oncology" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Ceritinib" (1 trials), "INC280 (capmatinib)" (1 trials), "INC280 single agent" (1 trials) and "erlotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NKI-AVL, Department of Thoracic-Oncology
The vast majority of trials in "NKI-AVL, Department of Thoracic-Oncology" are
3 trials for "All" genders.
Clinical Trials Status at NKI-AVL, Department of Thoracic-Oncology
Currently, there are NaN active trials in "NKI-AVL, Department of Thoracic-Oncology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in NKI-AVL, Department of Thoracic-Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NKI-AVL, Department of Thoracic-Oncology, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".